These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


232 related items for PubMed ID: 8384406

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
    Naidu R, Wahab NA, Yadav M, Kutty MK.
    Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
    [Abstract] [Full Text] [Related]

  • 23. [Comparison of nuclear accumulation of p53 protein with mutations in the p53 gene on the tissues of human breast cancer].
    Fan P, Wu Z, Cha X, Wang X, Wang S.
    Zhonghua Wai Ke Za Zhi; 1998 Nov; 36(11):655-7. PubMed ID: 11825490
    [Abstract] [Full Text] [Related]

  • 24. Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma.
    Turunen N, Karihtala P, Mantyniemi A, Sormunen R, Holmgren A, Kinnula VL, Soini Y.
    APMIS; 2004 Feb; 112(2):123-32. PubMed ID: 15056229
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma.
    Rey MJ, Fernández PL, Jares P, Muñoz M, Nadal A, Peiró N, Nayach I, Mallofré C, Muntané J, Campo E, Estapé J, Cardesa A.
    J Pathol; 1998 Mar; 184(3):265-71. PubMed ID: 9614378
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Bircan S, Kapucuoglu N, Baspinar S, Inan G, Candir O.
    Pathol Res Pract; 2006 Mar; 202(8):569-76. PubMed ID: 16828238
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Intraductal spread of invasive breast carcinoma has a positive correlation with c-erb B-2 overexpression and vascular invasion.
    Jing X, Kakudo K, Murakami M, Nakamura Y, Nakamura M, Yokoi T, Yang Q, Oura S, Sakurai T.
    Cancer; 1999 Aug 01; 86(3):439-48. PubMed ID: 10430252
    [Abstract] [Full Text] [Related]

  • 33. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
    Salvucci O, Bouchard A, Baccarelli A, Deschênes J, Sauter G, Simon R, Bianchi R, Basik M.
    Breast Cancer Res Treat; 2006 Jun 01; 97(3):275-83. PubMed ID: 16344916
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Apoptosis-related proteins (Fas, Fas ligand, bcl-2 and p53) in different types of human breast tumors.
    Ben-Hur H, Mordechay E, Halperin R, Gurevich P, Zandbank J, Herper M, Zusman I.
    Oncol Rep; 2002 Jun 01; 9(5):977-80. PubMed ID: 12168058
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. HER-2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger.
    Maru D, Middleton LP, Wang S, Valero V, Sahin A.
    Cancer; 2005 Mar 01; 103(5):900-5. PubMed ID: 15643600
    [Abstract] [Full Text] [Related]

  • 40. Different proliferative patterns characterize different preinvasive breast lesions.
    Viacava P, Naccarato AG, Bevilacqua G.
    J Pathol; 1999 Jul 01; 188(3):245-51. PubMed ID: 10419590
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.